查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863098

静脉注射针市场按产品类型、最终用户、应用、材料、规格和销售管道划分－2025-2032年全球预测

Intravenous Needles Market by Product Type, End User, Application, Material, Gauge, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，静脉注射针头市场规模将达到 35.3 亿美元，复合年增长率为 6.43%。

主要市场统计数据
基准年 2024 21.4亿美元
预计年份：2025年 22.8亿美元
预测年份：2032年 35.3亿美元
复合年增长率 (%) 6.43%

本文简要概述了临床、监管和供应链趋势如何影响静脉注射针市场，以及这些趋势对医疗保健领导者的影响。

静脉注射针头仍然是现代医疗保健服务的基础要素，它与临床疗效、病人安全和供应链韧性息息相关。本执行摘要总结了影响静脉输液针​​头生态系统的最主要趋势，探讨了临床趋势、监管压力、材料科学和分销演变，以及对医疗服务提供者和製造商的营运影响。本概要旨在为采购、产品开发、临床应用和市场拓展等方面的策略选择检验。

临床重点的趋同、材料创新以及流通结构的转变正在从根本上重新定义静脉注射针头产品的设计和商业化策略。

由于临床需求趋于一致、技术进步和分销管道创新，静脉注射针头领域正在经历变革。安全型皮下注射针和输液的显着普及，反映了人们对职业安全、病患疗效和感染控制的日益重视。製造商投资于被动安全功能和一次性使用设计，以满足临床医生的需求和医疗机构的政策，从而降低锐器伤和交叉感染的风险。

2025 年美国关税环境正在推动供应链重组、离岸外包考量和策略采购，以维持安全和业务连续性。

2025年，美国关税政策和不断变化的贸易环境为医疗设备价值链上的采购和製造策略带来了新的挑战。影响原材料和成品的关税调整将影响工厂位置、供应商多元化和库存分配决策。对于依赖跨境供应零件、原材料和成品的公司而言，货物运输成本的增加正促使它们重新评估企业发展，并考虑近岸外包的机会。

透过对产品、最终用户、应用、材料、规格和销售管道差异进行详细分析，实现整合式市场细分，从而帮助制定有针对性的策略。

一套完善的市场区隔框架对于了解需求驱动因素并将产品系列与使用者需求相匹配至关重要。根据产品类型，市场可细分为皮下注射针和输液针。皮下注射针本身又包括常规注射针、胰岛素注射针和安全注射针，其中安全注射针可进一步细分为主动安全注射针和被动安全注射针。输液针包括套针式导管和翼型输液针。套针式导管又可分为中央静脉导管和周边静脉导管，而翼型输液针则可区分为可重复使用型和一次性使用型。

区域因素（美洲、欧洲、中东和非洲、亚太地区）将影响设备设计、法规遵循和市场推广策略。

区域特征显着影响医疗设备的设计趋势、监管管道和分销模式。在美洲，先进的医院网路和不断扩展的门诊服务正在塑造临床需求，买家优先考虑安全性高的器械和稳定的供应链。该地区的支付体系和采购整合有利于可扩展的产品，这些产品可以在大规模综合医疗网路中实现标准化，从而促使製造商专注于经济高效的安全解决方案和高效的合约流程。

产业领导者如何将安全工程、在地化生产和多元化的商业模式结合，以巩固其市场地位并促进临床应用？

静脉输液针​​生态系统的竞争日益激烈，其表现为对安全工程、卓越製造流程和多元化销售管道的持续投入。主要企业正优先考虑实施先进的安全功能，例如减少对医护人员依赖的被动式系统，以及提升频繁操作时易用性的人体工学设计。这些产品投入通常与强化的品管系统和更丰富的临床证据相结合，以吸引那些规避风险的医疗机构买家。

针对製造商、采购团队和临床领导者，专注于营运和策略步骤，以提高韧性、安全措施的采纳率和产品上市速度。

为了应对不断变化的静脉输液针​​头环境，生产、采购和临床营运负责人应优先进行一系列协调工作。首先，使产品系列与临床工作流程保持一致，重点关注安全的设计方案以及针对门诊和居家医疗应用优化的设计。这种一致性有助于临床应用，同时也能满足职业安全要求。

我们采用严谨的混合调查方法，结合临床医生和采购负责人的原始资讯、监管审查和技术分析，以确保实际可靠性。

本研究综合分析基于结构化的调查方法，融合了第一手和第二手研究方法，以确保获得可靠且可操作的见解。第一手资料包括对临床医生、采购人员、监管专家和医疗设备工程师的结构化访谈，从而获得关于临床偏好、实施障碍和营运限制的第一手观点。此外，还与供应链和报销专家进行了咨询，以了解影响医疗设备选择的商业和物流因素。

整合产业趋势和策略要务，强调安全至上的设计、供应链韧性和跨职能执行，以实现持续的临床应用。

静脉输液针​​市场正处于一个转折点，临床安全期望、分散式医疗服务模式和供应链动态的交汇融合，既带来了挑战，也带来了机会。采用安全、符合人体工学的器材和设计，使其适用于门诊和居家医疗环境，对于适应不断变化的临床实践和降低职业风险至关重要。投资于材料创新、人性化设计和完善品质系统的製造商，将更有能力满足临床医生的需求并应对监管机构的审查。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 为减少针刺伤，对更安全的静脉注射针头的需求日益增长
  • 将抗菌涂层整合到静脉注射针头中，以预防导管相关感染
  • 扩大在针头製造中使用环保型、可生物降解材料的范围，以减少医疗废弃物。
  • 进一步客製化针头规格和长度，以适应不同患者群体
  • 照护现场诊断采血针的进展
  • 越来越多地采用无针连接器和整合式静脉输液系统，以简化输液治疗流程。
  • 加强对一次性静脉输液针​​系统的监管，以提高无菌性和病人安全性。

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 依产品类型分類的静脉注射针市场

  • 皮下注射针
    • 普通针头
    • 胰岛素针
    • 安全针
      • 主动安全装置
      • 被动式安全装置
  • 点滴针
    • 针式导管
      • 中央静脉导管
      • 週边导管
    • 带翼输液针
      • 多用途
      • 一次使用

9. 按最终用户分類的静脉注射针市场

  • 门诊治疗
    • 急诊中心
    • 手术中心
  • 诊所
    • 诊断诊所
    • 专科诊所
  • 居家医疗
    • 慢性病护理
    • 术后护理
  • 医院
    • 私立医院
    • 公立医院

第十章 按应用分類的静脉注射针市场

  • 血液收集
    • 毛细管采样
    • 静脉血采样
  • 化疗
    • 鞘内给药
    • 静脉化疗
  • 药物管理
    • Bolus注
    • 持续输注

第十一章 依材质分類的静脉注射针市场

  • 镀镍
  • 塑胶
    • 聚丙烯
    • PVC
  • 防锈的
    • 医用级
    • 手术等级

12. 按规格分類的静脉注射针市场

  • 薄规格
  • 中轨
  • 厚规格

第十三章 按销售管道分類的静脉注射针市场

  • 直销
    • 机构合约
    • 本地销售
  • 经销商
    • 零售药房
    • 批发商
  • 电子商务
    • B2B
    • B2C

14. 各地区静脉注射针头市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 按类别分類的静脉注射针市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国静脉注射针市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Becton, Dickinson and Company
    • B. Braun Melsungen Aktiengesellschaft
    • Terumo Corporation
    • ICU Medical, Inc.
    • Smiths Group plc
    • Cardinal Health, Inc.
    • Nipro Corporation
    • Teleflex Incorporated
    • Fresenius Kabi AG
    • Medline Industries, LP
Product Code: MRR-F6513A06BEEA

The Intravenous Needles Market is projected to grow by USD 3.53 billion at a CAGR of 6.43% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.14 billion
Estimated Year [2025] USD 2.28 billion
Forecast Year [2032] USD 3.53 billion
CAGR (%) 6.43%

A concise orientation to the clinical, regulatory, and supply chain forces reshaping intravenous needles and their implications for healthcare leaders

Intravenous needles remain a foundational element of modern healthcare delivery, intersecting clinical efficacy, patient safety, and supply chain resilience. This executive summary synthesizes the most salient dynamics shaping the intravenous and infusion needle ecosystem, examining clinical trends, regulatory pressures, materials science, distribution evolution, and the operational implications for providers and manufacturers. It is designed to inform strategic choices across procurement, product development, clinical practice, and market engagement.

The landscape of vascular access devices has shifted markedly as healthcare systems prioritize safety-engineered devices, outpatient infusion care, and home-administered therapies. Concurrently, advances in materials and design are reshaping clinician preferences and patient comfort while regulatory frameworks tighten requirements around safety mechanisms and traceability. These trends intersect with channel transformation, as e-commerce and distributor models complement institutional contracting to reach diverse end users from ambulatory centers to homecare settings.

This introduction frames the subsequent sections, which detail transformative shifts in clinical practice and market structure, analyze tariff impacts within the United States trade environment for 2025, unpack segmentation insights across product, end user, application, material, gauge, and sales channel, and provide regional and corporate perspectives. The goal is to present actionable context that leaders can apply to reduce clinical risk, strengthen procurement strategies, and prioritize innovation investments.

How converging clinical priorities, material innovations, and distribution shifts are fundamentally redefining product design and commercialization strategies for intravenous needles

The intravenous needles sector is undergoing transformative change driven by converging clinical priorities, technological advancement, and distribution innovation. A pronounced shift toward safety-engineered hypodermic needles and infusion solutions reflects heightened emphasis on occupational safety, patient outcomes, and infection control. Manufacturers that invest in passive safety mechanisms and devices engineered for single use are aligning with clinician demands and institutional policies that reduce sharps injuries and cross-contamination risks.

Simultaneously, the rise of outpatient care and home-based therapies is recalibrating product requirements. Infusion needles designed for over-the-needle catheters and winged infusion tips are being optimized for ease of use in non-hospital environments, with attention to ergonomic design, secure fixation, and simplified dressing interfaces. These changes are complemented by material innovations; the incorporation of medical-grade plastics and refined stainless-steel alloys improves device compatibility with prolonged therapies and reduces adverse interactions with drug formulations.

On the commercial side, sales channels are diversifying. Direct institutional contracting remains essential for hospitals and large networks, while distributors and e-commerce platforms expand reach into clinics, ambulatory centers, and homecare purchasers. This channel plurality demands sharper segmentation of sales approaches and supply chain elasticity. Finally, heightened regulatory scrutiny and traceability expectations are prompting manufacturers to enhance quality management systems and invest in packaging and serialization technologies to meet compliance and safety reporting needs.

The 2025 United States tariff environment prompting supply chain realignment, nearshoring considerations, and strategic sourcing to preserve safety and operational continuity

In 2025, changes to tariff policy and trade dynamics in the United States have imposed new considerations on sourcing and manufacturing strategies across the medical device value chain. Tariff adjustments affecting inputs and finished devices can influence decisions around facility placement, supplier diversification, and inventory positioning. For companies that rely on cross-border supply flows for components, raw materials, or finished goods, the increased cost of moving goods has incentivized reevaluation of global footprint and nearshoring opportunities.

These trade pressures have prompted operational leaders to assess total landed cost more rigorously, factoring in duties, logistics volatility, and customs compliance complexity. As a result, many organizations are intensifying supplier qualification processes, seeking alternative material sources that reduce tariff exposure, and negotiating long-term agreements to stabilize pricing. Regulatory teams are also working more closely with trade and legal functions to ensure classification and documentation minimize unnecessary duty burdens.

From a clinical procurement perspective, the tariff environment has accelerated collaboration between purchasing groups and clinical end users to balance cost containment with device performance and safety outcomes. Hospitals and integrated delivery networks are increasingly focused on demand forecasting accuracy and strategic stockholding policies to mitigate price and supply fluctuations. Overall, the tariff-driven environment of 2025 is accelerating supply chain modernization and strategic sourcing initiatives that prioritize resilience without compromising safety or clinical efficacy.

A detailed segmentation synthesis highlighting product, end user, application, material, gauge, and sales channel distinctions to inform targeted strategies

A nuanced segmentation framework is essential for understanding demand drivers and aligning product portfolios to user needs. Based on product type, the market divides between hypodermic needles and infusion needles. Hypodermic needles themselves encompass conventional needles, insulin needles, and safety needles, with safety needles further subdividing into active safety and passive safety options. Infusion needles include over-the-needle catheters and winged infusion tips; over-the-needle catheters differentiate into central venous catheters and peripheral catheters, while winged infusion tips are distinguished by multi use and single use configurations.

End-user segmentation captures the variety of care settings where devices are applied, spanning ambulatory, clinics, homecare, and hospitals. Ambulatory care settings can be further categorized into emergency centers and surgery centers, whereas clinics encompass diagnostic clinics and specialty clinics. Homecare demand often arises from chronic care and post operative care scenarios, and hospitals include both private and public institutions with differing procurement structures and clinical protocols.

Application-driven segmentation clarifies clinical intent and device requirements, separating use cases into blood sampling, chemotherapy, and drug administration. Blood sampling requires devices appropriate for capillary sampling or venous sampling, chemotherapy applications divide between intrathecal administration and intravenous chemotherapy, and drug administration differentiates between bolus injection and continuous infusion methodologies.

Materials-based segmentation reflects performance and compatibility priorities, differentiating nickel plated, plastic, and stainless steel options. Plastic materials include polypropylene and PVC variants, while stainless-steel distinctions are made between medical grade and surgical grade alloys. Gauge classifications-fine gauge, medium gauge, and thick gauge-affect procedure suitability and patient comfort. Sales-channel segmentation recognizes direct sales, distributors, and e-commerce as primary routes; direct sales often operate through institutional contracts and on-site sales, distributors serve retail pharmacies and wholesalers, and e-commerce spans both B2B and B2C models. Understanding these layered segments enables targeted product development, regulatory planning, and commercial strategies that align with specific clinical workflows and procurement practices.

Regional considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping device design, regulatory compliance, and go-to-market approaches

Regional dynamics exert a powerful influence on device design preferences, regulatory pathways, and distribution models. In the Americas, clinical demand is shaped by a mix of advanced hospital networks and expanding outpatient care, with purchasers placing emphasis on safety-engineered devices and robust supply chain continuity. Payment systems and procurement consolidation in this region also favor scalable products that can be standardized across large integrated delivery networks, encouraging manufacturers to focus on cost-effective safety solutions and streamlined contracting processes.

In Europe, Middle East & Africa, regulatory heterogeneity and diverse healthcare delivery settings require adaptable compliance strategies and flexible distribution partnerships. European regulatory frameworks typically demand rigorous conformity assessment, creating a market environment where traceability and quality systems are critical. In the Middle East and Africa, differing levels of healthcare infrastructure and procurement capacity make distributor relationships and localized training programs pivotal for market penetration.

Asia-Pacific presents a complex mix of mature and rapidly developing markets, driving demand for both premium, technically advanced devices and lower-cost, high-volume options. Local manufacturing capacity and government procurement policies in some markets create opportunities for partnerships and joint ventures. Across the region, the growth of outpatient and homecare services is encouraging suppliers to design devices optimized for non-hospital settings, while regulatory authorities are increasingly harmonizing standards to facilitate cross-border product movement.

Across all regions, manufacturers and suppliers must balance global quality standards with locally relevant product configurations, training, and commercialization approaches to achieve clinical adoption and supply reliability.

How industry leaders are combining safety engineering, local production, and diversified commercial models to strengthen market position and clinical adoption

Competitive dynamics in the intravenous needles ecosystem are defined by investments in safety engineering, manufacturing excellence, and channel diversification. Leading companies are prioritizing advanced safety mechanisms, including passive systems that reduce reliance on clinician activation, and refinements to device ergonomics that enhance handling during high-throughput procedures. These product investments are frequently paired with stronger quality management systems and expanded clinical evidence to support adoption among risk-averse institutional buyers.

Manufacturers are also differentiating through vertical integration and local production capacity to mitigate trade-related cost exposure and improve supply responsiveness. Strategic partnerships with contract manufacturers, material suppliers, and logistics providers enable scalable production while maintaining compliance with stringent medical device standards. In parallel, some companies are expanding service offerings-such as training, clinical support, and device management programs-to strengthen customer relationships and embed products within clinical protocols.

Commercial models are diversifying, with players investing in direct contracting capabilities for large hospital systems while simultaneously expanding distributor networks and e-commerce platforms to reach smaller clinics and homecare markets. Mergers and acquisitions remain a tactical option for acquiring complementary technologies, entering adjacent segments like catheter-based systems, or accelerating entry into high-growth care settings. Finally, firms that demonstrate proactive regulatory engagement and transparent supply chain practices tend to build stronger trust with healthcare providers and procurement professionals.

Focused operational and strategic steps for manufacturers, procurement teams, and clinical leaders to improve resilience, safety adoption, and go-to-market effectiveness

Leaders in manufacturing, procurement, and clinical operations should prioritize a cohesive set of actions to navigate the changing intravenous needles environment. First, align product portfolios to clinical workflows by emphasizing safety- engineered solutions and designs optimized for outpatient and homecare use. This alignment will support clinical adoption while addressing occupational safety imperatives.

Second, accelerate supplier diversification and onshoring where feasible to reduce exposure to tariff volatility and logistics disruption. Complement this with rigorous supplier qualification and dual-sourcing strategies that preserve product quality. Third, invest in regulatory readiness and serialization capabilities to meet evolving traceability and reporting requirements; doing so will reduce time-to-market friction and improve compliance resilience.

Fourth, tailor commercial approaches by segmenting customers across hospitals, ambulatory centers, clinics, and homecare, and design channel-specific value propositions. For large institutional buyers, bundle device supply with training and device management services; for clinics and homecare channels, focus on simplified packaging and e-commerce accessibility. Fifth, strengthen clinical evidence generation through targeted trials and real-world data collection that demonstrate safety and usability benefits, thereby supporting procurement rationales and clinician buy-in.

Implementing these recommendations requires cross-functional coordination between R&D, regulatory, supply chain, and commercial teams to translate strategic intent into operational outcomes that prioritize patient safety and market responsiveness.

A rigorous mixed-methods research approach combining primary clinician and procurement insights with regulatory review and technical analysis to ensure practical reliability

This research synthesis draws on a structured methodology that blends primary and secondary investigative approaches to ensure robust, actionable insights. Primary inputs include structured interviews with clinicians, procurement leaders, regulatory specialists, and device engineers, providing firsthand perspectives on clinical preferences, adoption barriers, and operational constraints. These interviews were complemented by advisory consultations with supply chain and reimbursement experts to understand the commercial and logistical dimensions influencing device selection.

Secondary research involved systematic review of regulatory frameworks, clinical guidelines, device standards, and published peer-reviewed literature to ground findings in authoritative sources. Product specifications, patent filings, and materials data were analyzed to identify technological trends and material innovations. Market-facing information from distributor networks, procurement consortiums, and hospital formularies informed channel and end-user dynamics.

Analytical techniques included segmentation mapping, scenario analysis to assess tariff and supply risk implications, and comparative evaluation of design features against clinical requirements. Quality assurance processes involved cross-validation of primary responses with documentary evidence and internal peer review. Ethical considerations and participant confidentiality were maintained throughout primary data collection, and all claims were corroborated by multiple sources where possible to enhance reliability.

Synthesis of sector trajectories and strategic imperatives emphasizing safety-focused design, supply resilience, and cross-functional execution for sustained clinical adoption

The intravenous needles landscape is at an inflection point where clinical safety expectations, care-delivery decentralization, and supply chain dynamics converge to create both challenges and opportunities. Embracing safety- engineered devices and designs suited to outpatient and homecare settings will be essential for aligning with evolving clinical practice and reducing occupational risk. Manufacturers that invest in materials innovation, intuitive design, and robust quality systems will be better positioned to meet clinicians' needs and regulatory scrutiny.

At the same time, supply chain resilience should be a strategic priority. Nearshoring, dual sourcing, and stronger supplier governance will help organizations manage tariff exposure and logistical volatility while preserving product quality. Commercial strategies must become more granular, balancing direct institutional engagement with distributor partnerships and digital channels to address the needs of diverse end users.

Ultimately, success in this sector will depend on cross-functional collaboration across R&D, regulatory, clinical, and commercial teams. Organizations that translate insight into targeted product offerings, evidence generation, and adaptive supply models will achieve higher rates of clinical adoption and operational continuity. The recommendations and perspectives in this summary provide a foundation for pragmatic action to improve safety outcomes and sustain market relevance in a rapidly evolving environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for safety-engineered intravenous needles to reduce needlestick injuries
  • 5.2. Integration of antimicrobial coatings on intravenous needles to prevent catheter-related infections
  • 5.3. Growing adoption of eco-friendly and biodegradable materials in needle manufacturing to reduce medical waste
  • 5.4. Increasing customization of needle gauge sizes and lengths to support diverse patient demographics
  • 5.5. Advances in autologous blood sampling-compatible intravenous needles for point-of-care diagnostics
  • 5.6. Expansion of needleless connectors and integrated IV systems to streamline infusion therapy workflows
  • 5.7. Regulatory push for single-use intravenous needle systems to enhance sterility and patient safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Needles Market, by Product Type

  • 8.1. Hypodermic Needles
    • 8.1.1. Conventional Needles
    • 8.1.2. Insulin Needles
    • 8.1.3. Safety Needles
      • 8.1.3.1. Active Safety
      • 8.1.3.2. Passive Safety
  • 8.2. Infusion Needles
    • 8.2.1. Over The Needle Catheters
      • 8.2.1.1. Central Venous Catheters
      • 8.2.1.2. Peripheral Catheters
    • 8.2.2. Winged Infusion Tips
      • 8.2.2.1. Multi Use
      • 8.2.2.2. Single Use

9. Intravenous Needles Market, by End User

  • 9.1. Ambulatory
    • 9.1.1. Emergency Centers
    • 9.1.2. Surgery Centers
  • 9.2. Clinics
    • 9.2.1. Diagnostic Clinics
    • 9.2.2. Specialty Clinics
  • 9.3. Homecare
    • 9.3.1. Chronic Care
    • 9.3.2. Post Operative Care
  • 9.4. Hospitals
    • 9.4.1. Private Hospitals
    • 9.4.2. Public Hospitals

10. Intravenous Needles Market, by Application

  • 10.1. Blood Sampling
    • 10.1.1. Capillary Sampling
    • 10.1.2. Venous Sampling
  • 10.2. Chemotherapy
    • 10.2.1. Intrathecal Administration
    • 10.2.2. Intravenous Chemotherapy
  • 10.3. Drug Administration
    • 10.3.1. Bolus Injection
    • 10.3.2. Continuous Infusion

11. Intravenous Needles Market, by Material

  • 11.1. Nickel Plated
  • 11.2. Plastic
    • 11.2.1. Polypropylene
    • 11.2.2. PVC
  • 11.3. Stainless Steel
    • 11.3.1. Medical Grade
    • 11.3.2. Surgical Grade

12. Intravenous Needles Market, by Gauge

  • 12.1. Fine Gauge
  • 12.2. Medium Gauge
  • 12.3. Thick Gauge

13. Intravenous Needles Market, by Sales Channel

  • 13.1. Direct Sales
    • 13.1.1. Institutional Contracts
    • 13.1.2. On Site Sales
  • 13.2. Distributors
    • 13.2.1. Retail Pharmacies
    • 13.2.2. Wholesalers
  • 13.3. E Commerce
    • 13.3.1. B2B
    • 13.3.2. B2C

14. Intravenous Needles Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Intravenous Needles Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Intravenous Needles Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Becton, Dickinson and Company
    • 17.3.2. B. Braun Melsungen Aktiengesellschaft
    • 17.3.3. Terumo Corporation
    • 17.3.4. ICU Medical, Inc.
    • 17.3.5. Smiths Group plc
    • 17.3.6. Cardinal Health, Inc.
    • 17.3.7. Nipro Corporation
    • 17.3.8. Teleflex Incorporated
    • 17.3.9. Fresenius Kabi AG
    • 17.3.10. Medline Industries, LP

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAVENOUS NEEDLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSTITUTIONAL CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL INTRAVEN